Lv51
878 积分 2023-01-12 加入
Anatomic Versus Non-anatomic Liver Resection for Intrahepatic Cholangiocarcinoma: A Systematic Review and Patient-Level Meta-Analysis
7小时前
已完结
Tumor-draining lymph nodes: At the crossroads of metastasis and immunity
4天前
已完结
Lymph node resection does not impair cancer immunotherapy responses
11天前
已完结
Systemic immunity in cancer
11天前
已完结
Immunogenicity Challenges Associated with Subcutaneous Delivery of Therapeutic Proteins
11天前
已完结
Adjuvant lenvatinib in combination with transarterial chemoembolization for hepatocellular carcinoma patients with high risk of postoperative recurrence: A multicenter prospective cohort study
21天前
已完结
Perioperative camrelizumab plus rivoceranib versus surgery alone in patients with resectable hepatocellular carcinoma at intermediate or high risk of recurrence (CARES-009): a randomised phase 2/3 trial
27天前
已完结
Perioperative camrelizumab plus rivoceranib versus surgery alone in patients with resectable hepatocellular carcinoma at intermediate or high risk of recurrence (CARES-009): a randomised phase 2/3 trial
27天前
已完结
Atezolizumab plus bevacizumab versus active surveillance in patients with resected or ablated high-risk hepatocellular carcinoma (IMbrave050): a randomised, open-label, multicentre, phase 3 trial
1个月前
已完结
皖公网安备34019202002308
